NDC 71288-713 – Cisatracurium Besylate
Cisatracurium Besylate 200 mg/20mL · Injection, Solution · Intravenous
Product NDC71288-713
Product details
- Brand name
- Cisatracurium Besylate
- Generic name
- Cisatracurium Besylate
- Labeler
- Meitheal Pharmaceuticals Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA211668
- Marketed since
- October 31, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Nondepolarizing Neuromuscular Blocker
Active ingredients
- Cisatracurium Besylate 200 mg/20mL
Uses, dosage, side effects and warnings for Cisatracurium Besylate →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 71288-713-21 | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-713-21) / 20 mL in 1 VIAL, SINGLE-DOSE (71288-713-20) | Oct 31, 2019 |
| 71288-713-96 | 10 VIAL, SINGLE-DOSE in 1 CARTON (71288-713-96) / 20 mL in 1 VIAL, SINGLE-DOSE (71288-713-95) | Oct 31, 2019 |
Recalls mentioning this NDC
- D-0286-2021 Mar 3, 2021 · Class I
Labeling: Label mix-up: Carton of Cisatracurium Besylate Injection, USP was observed to contain ten vials mislabeled as Phenylephrine Hydrochloride Injection, USP, but confirmed to contain…
Other Cisatracurium Besylate products
- 83634-655 Cisatracurium Besylate 10 mg/mL · Injection, Solution · Avenacy, LLC
- 0409-1098 Cisatracurium Besylate 2 mg/mL · Injection, Solution · Hospira, Inc.
- 0409-1103 Cisatracurium Besylate 10 mg/mL · Injection, Solution · Hospira, Inc.
- 0409-1208 Cisatracurium Besylate 2 mg/mL · Injection, Solution · Hospira, Inc.
- 71288-712 Cisatracurium Besylate 10 mg/5mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 71288-714 Cisatracurium Besylate 20 mg/10mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 72485-513 Cisatracurium Besylate 200 mg/20mL · Injection · Armas Pharmaceuticals
- 31722-312 Cisatracurium Besylate 10 mg/mL · Injection · Camber Pharmaceuticals Inc.
- 31722-313 Cisatracurium Besylate 2 mg/mL · Injection · Camber Pharmaceuticals Inc.
- 31722-314 Cisatracurium Besylate 2 mg/mL · Injection · Camber Pharmaceuticals Inc.
- 65145-137 Cisatracurium Besylate 10 mg/mL · Injection · Caplin Steriles Limited
- 65145-136 Cisatracurium Besylate 2 mg/mL · Injection · Caplin Steriles Limited